TIFFANY MEYER: Open Payments
NPI 1477990836 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 39 payments from 10 companies in 2025. Trend: 2023 $164 · 2024 $971 · 2025 $779
Food & beverage: $672Education: $107
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $230 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $140 |
| ABBVIE INC. | 5 | $90 |
| PFIZER INC. | 4 | $83 |
| Ardelyx, Inc. | 3 | $60 |
| Madrigal Pharmaceuticals | 2 | $48 |
| Lilly USA, LLC | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 3 | $30 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
Products named: TREMFYA, ENTYVIO, XELJANZ, IBSRELA, LINZESS, REZDIFFRA, OMVOH, EOHILIA.
Industry payments across NY — which companies pay providers there.
